JPWO2021086899A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021086899A5 JPWO2021086899A5 JP2022523575A JP2022523575A JPWO2021086899A5 JP WO2021086899 A5 JPWO2021086899 A5 JP WO2021086899A5 JP 2022523575 A JP2022523575 A JP 2022523575A JP 2022523575 A JP2022523575 A JP 2022523575A JP WO2021086899 A5 JPWO2021086899 A5 JP WO2021086899A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- isolated antibody
- pharmaceutical composition
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926914P | 2019-10-28 | 2019-10-28 | |
| US62/926,914 | 2019-10-28 | ||
| US202063094170P | 2020-10-20 | 2020-10-20 | |
| US63/094,170 | 2020-10-20 | ||
| PCT/US2020/057635 WO2021086899A1 (en) | 2019-10-28 | 2020-10-28 | Anti-hemagglutinin antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553703A JP2022553703A (ja) | 2022-12-26 |
| JPWO2021086899A5 true JPWO2021086899A5 (sl) | 2023-09-26 |
Family
ID=73498317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523575A Pending JP2022553703A (ja) | 2019-10-28 | 2020-10-28 | 抗血球凝集素抗体およびその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11773156B2 (sl) |
| EP (1) | EP4051707A1 (sl) |
| JP (1) | JP2022553703A (sl) |
| KR (1) | KR20220088446A (sl) |
| CN (1) | CN114761428A (sl) |
| AU (1) | AU2020374878A1 (sl) |
| BR (1) | BR112022007923A2 (sl) |
| CA (1) | CA3153944A1 (sl) |
| CL (1) | CL2022001067A1 (sl) |
| CO (1) | CO2022005281A2 (sl) |
| IL (1) | IL292353A (sl) |
| WO (1) | WO2021086899A1 (sl) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| US7850962B2 (en) | 2004-04-20 | 2010-12-14 | Genmab A/S | Human monoclonal antibodies against CD20 |
| US8257740B1 (en) | 2011-08-15 | 2012-09-04 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| US8246995B2 (en) | 2005-05-10 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| MY159787A (en) | 2006-06-02 | 2017-01-31 | Regeneron Pharma | High affinity antibodies to human il-6 receptor |
| KR101747103B1 (ko) | 2009-06-26 | 2017-06-14 | 리제너론 파마슈티칼스 인코포레이티드 | 천연 면역글로불린 포맷을 가지는 용이하게 분리된 이중특이성 항체 |
| RS55315B2 (sr) | 2010-02-08 | 2020-08-31 | Regeneron Pharma | Miš sa zajedničkim lakim lancem |
| CN104245731B (zh) * | 2012-01-31 | 2017-04-05 | 株式会社医学生物学研究所 | 抗乙型流感病毒的广泛保护性人单克隆抗体及其使用方法 |
| RU2644684C2 (ru) * | 2012-03-16 | 2018-02-13 | Регенерон Фармасьютикалз, Инк. | Антитела со встроенным в легкие цепи гистидином и генетически модифицированные отличные от человека животные для их получения |
| TWI635098B (zh) | 2013-02-01 | 2018-09-11 | 再生元醫藥公司 | 含嵌合恆定區之抗體 |
| US10639370B2 (en) | 2014-02-04 | 2020-05-05 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| BR112016018082A2 (pt) | 2014-02-04 | 2018-02-20 | Contrafect Corporation | ?anticorpos úteis na imunização passiva de influenza e composições, combinações e métodos para uso dos mesmos? |
| CA2942820A1 (en) | 2014-03-27 | 2015-10-01 | Genentech, Inc. | Anti-influenza b virus hemagglutinin antibodies and methods of use |
| CA2954780A1 (en) * | 2014-07-15 | 2016-01-21 | Medimmune, Llc | Neutralizing anti-influenza b antibodies and uses thereof |
| CN113480640B (zh) * | 2015-06-01 | 2024-07-30 | 免疫医疗有限责任公司 | 中和抗流感结合分子及其用途 |
| JP6423550B2 (ja) | 2015-06-03 | 2018-11-14 | シャアメン ユニバーシティ | 広域スペクトルモノクローナル抗ＦｌｕＢ抗体およびその使用 |
-
2020
- 2020-10-28 KR KR1020227016672A patent/KR20220088446A/ko unknown
- 2020-10-28 AU AU2020374878A patent/AU2020374878A1/en active Pending
- 2020-10-28 BR BR112022007923A patent/BR112022007923A2/pt unknown
- 2020-10-28 WO PCT/US2020/057635 patent/WO2021086899A1/en unknown
- 2020-10-28 IL IL292353A patent/IL292353A/en unknown
- 2020-10-28 JP JP2022523575A patent/JP2022553703A/ja active Pending
- 2020-10-28 CA CA3153944A patent/CA3153944A1/en active Pending
- 2020-10-28 EP EP20811191.4A patent/EP4051707A1/en active Pending
- 2020-10-28 CN CN202080084529.XA patent/CN114761428A/zh active Pending
- 2020-10-28 US US17/082,375 patent/US11773156B2/en active Active
-
2022
- 2022-04-27 CL CL2022001067A patent/CL2022001067A1/es unknown
- 2022-04-27 CO CONC2022/0005281A patent/CO2022005281A2/es unknown
-
2023
- 2023-08-21 US US18/453,207 patent/US20240083983A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018503361A5 (sl) | ||
| EA036953B1 (ru) | Человеческие антитела против гемагглютинина вируса гриппа | |
| JP2018512435A5 (sl) | ||
| RU2015136392A (ru) | Композиции и способы, основанные на нейтрализующих антителах, доставляемых интраназально, для улучшенной терапевтической эффективности | |
| CN114173819A (zh) | 通过施用il-4r拮抗剂治疗过敏和增强过敏原特异性免疫疗法的方法 | |
| JP2022160685A5 (sl) | ||
| US20230227555A1 (en) | Cd-3 antibodies for the treatment of coronavirus | |
| IL275884B1 (en) | Human antibodies to influenza hemagglutinin | |
| JPWO2021086899A5 (sl) | ||
| EP2138513B1 (en) | Pharmaceutical compositions of antibodies for diseases caused by viruses | |
| CN115697378A (zh) | 用cgrp抑制剂治疗肺部损伤的方法 | |
| EP4204449A1 (en) | Method of treating an allergy with allergen-specific monoclonal antibodies | |
| JPWO2019147867A5 (sl) | ||
| WO2021216374A1 (en) | Pan-elr+ cxc chemokine antibodies for the treatment of respiratory disease | |
| US11773156B2 (en) | Anti-hemagglutinin antibodies and methods of use thereof | |
| WO2016189491A1 (en) | Novel formulation | |
| JPWO2022037531A5 (sl) | ||
| JPWO2021101975A5 (sl) | ||
| WO2024077113A1 (en) | Methods of treating fatigue in ulcerative colitis | |
| RU2024121393A (ru) | Способы ослабления атопического марша посредством введения антагониста il-4/il-13 | |
| RU2020140639A (ru) | Способы лечения атопического дерматита посредством введения ингибитора ил-4r | |
| TW202337497A (zh) | 鼻內調配物及抗sars-cov-2棘蛋白抗體 | |
| CN117679507A (zh) | IgM抗体及其应用 | |
| JPWO2021180821A5 (sl) | ||
| JPWO2021151031A5 (sl) |